UniProt | Protein Name |
---|---|
P32004 |
|
GO Term | Evidence Code | PMID |
---|---|---|
homophilic cell adhesion via plasma membrane adhesion molecules | ||
axon guidance | ||
positive regulation of axon extension | ||
neuron projection development | ||
cell-matrix adhesion |
GO Term | Evidence Code | PMID |
---|---|---|
axon guidance receptor activity | ||
protein binding | ||
protein domain specific binding |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
DO ID | Disease Name | Source |
---|---|---|
DOID:11634 | myxedema | |
DOID:117 | heart cancer | |
DOID:11716 | prediabetes syndrome | |
DOID:11771 | spontaneous ocular nystagmus | |
DOID:11836 | clubfoot | |
DOID:11870 | Pick's disease | |
DOID:1206 | Rett syndrome | |
DOID:12236 | primary biliary cholangitis | |
DOID:3498 | pancreatic ductal adenocarcinoma | |
DOID:12387 | nephrogenic diabetes insipidus |
HPO ID | HPO Term |
---|---|
HP:0000218 | High palate |
HP:0000238 | Hydrocephalus |
HP:0000252 | Microcephaly |
HP:0000256 | Macrocephaly |
HP:0000280 | Coarse facial features |
HP:0000486 | Strabismus |
HP:0000639 | Nystagmus |
HP:0000750 | Delayed speech and language development |
HP:0001181 | Adducted thumb |
HP:0001188 | Hand clenching |
Disease ID | Disease Name |
---|---|
ORPHA:306617 |
|
ORPHA:2182 |
|
OMIM:304100 |
|
ORPHA:1497 |
|
OMIM:303350 |
|
OMIM:307000 |
|
ORPHA:2466 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
100525324 | PIGXX38257 | ||
516017 | BOVIN36513 | ||
102181196 | CAPHI31857 | ||
101110032 | SHEEP19986 | ||
100328746 | RABIT16634 | ||
106000173 | DIPOR22359 | ||
100769119 | CRIGR15537 | ||
16728 | MGI:96721 | MOUSE64996 | |
50687 | RGD:619777 | RATNO44750 | |
100726067 | CAVPO23721 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024